Department of Pathology & Genomic Medicine

Medicine & Life Sciences

1. Adenocarcinoma 35%
2. Adenocarcinoma of Lung 11%
3. Allografts 14%
4. Antibodies 20%
5. Antigens 14%
6. Apoptosis 11%
7. B-Lymphocytes 10%
8. Biomarkers 12%
9. Biopsy 37%
10. Blood Vessels 11%
11. Bone and Bones 10%
12. Breast 10%
13. Breast Neoplasms 13%
14. Carcinoma 65%
15. Cell Biology 24%
16. Child 10%
17. Clone Cells 18%
18. Coloring Agents 10%
19. Coronavirus 11%
20. Cysteine Proteases 10%
21. Differential Diagnosis 12%
22. DNA 28%
23. Drug Therapy 18%
24. Electrons 10%
25. Enzymes 12%
26. Epithelial Cells 10%
27. Epithelium 10%
28. Eye 12%
29. Fibrosis 10%
30. Fine Needle Biopsy 16%
31. gamma-Glutamyltransferase 10%
32. Gene Expression 13%
33. Genes 42%
34. Genome 19%
35. Genotype 9%
36. Growth 17%
37. HIV 10%
38. Hyperplasia 11%
39. Immunoglobulin G 9%
40. Immunohistochemistry 16%
41. In Vitro Techniques 12%
42. Incidence 10%
43. Infections 27%
44. Keratins 14%
45. Kidney 57%
46. Kidney Transplantation 11%
47. Liver 9%
48. Lung 40%
49. Lung Neoplasms 11%
50. Lymph Nodes 16%
51. Lymphoma 15%
52. Lymphoma, Large B-Cell, Diffuse 16%
53. Macrophages 19%
54. Mortality 11%
55. Mutation 26%
56. Mycobacterium tuberculosis 47%
57. Neoplasm Metastasis 32%
58. Neoplasms 100%
59. Non-Small Cell Lung Carcinoma 10%
60. Osteosarcoma 17%
61. Ovarian Neoplasms 13%
62. Ovary 12%
63. Pancreas 13%
64. Pancreas Transplantation 10%
65. Papanicolaou Test 14%
66. Pathologists 33%
67. Pathology 28%
68. Pharmaceutical Preparations 11%
69. Pharyngitis 10%
70. Phenotype 15%
71. Population 13%
72. Prostate 32%
73. Prostatic Neoplasms 20%
74. Proteins 25%
75. Radiotherapy 9%
76. Recurrence 16%
77. Renal Cell Carcinoma 37%
78. Retinoblastoma 16%
79. Rhodobacter sphaeroides 9%
80. Sarcoma 14%
81. Serogroup 26%
82. Serum 13%
83. Squamous Cell Carcinoma 10%
84. Squamous Intraepithelial Lesions 10%
85. Staining and Labeling 20%
86. Staphylococcus aureus 13%
87. Streptococcus 63%
88. Streptococcus pyogenes 33%
89. Survival 26%
90. T-Lymphocytes 19%
91. Therapeutics 25%
92. Tissue Donors 11%
93. Transitional Cell Carcinoma 13%
94. Transplant Recipients 14%
95. Transplants 23%
96. Tuberculosis 45%
97. Urinary Bladder 24%
98. Urinary Bladder Neoplasms 12%
99. Virulence 26%
100. Virulence Factors 14%